Indication
Chronic Inflammation
7 clinical trials
9 products
1 drug
Clinical trial
Effect of Maolactin™ FMR Supplementation on Exercise Recovery, Inflammation, and Muscle Comfort in an Otherwise Healthy Population: A Double-blind Randomized Placebo-controlled StudyStatus: Not yet recruiting, Estimated PCD: 2025-04-30
Product
MaolactinProduct
MaltodextrinClinical trial
CBD-induced Biomarkers of Inflammation Reduction in People Living With HIV at the Single Cell LevelStatus: Completed, Estimated PCD: 2022-12-12
Product
CBD oilClinical trial
Gulf War Illness Inflammation Reduction TrialStatus: Completed, Estimated PCD: 2023-10-19
Product
Modified-Release PrednisoneProduct
PlaceboClinical trial
Single-group, Open-label, Phase I / II Clinical Trial: Evaluating the Safety and Efficacy of Autologous Adipose Tissue-derived Mesenchymal Stem Cell Transplantation on Proinflammatory Cytokines and Cytokines Balance in Inflammaging (Ageing-related Low-grade Inflammation) Patients.Status: Recruiting, Estimated PCD: 2025-04-13
Clinical trial
Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes: A Randomized, Double-blind, Placebo-controlled, Investigator-initiated TrialStatus: Recruiting, Estimated PCD: 2026-06-15
Product
ColchicineDrug
VarlilumabClinical trial
The Effect of Ferric Citrate on Inflammation and Lipid Levels in Patients on HemodialysisStatus: Terminated, Estimated PCD: 2017-09-29
Product
Ferric CitrateClinical trial
A Randomized Parallel Comparison of Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)Status: Recruiting, Estimated PCD: 2023-12-31
Product
Semaglutide